Cannabinoid Teratogenicity

Cannabinoid Teratogenicity is a toxicological construct that denotes the potential of cannabinoids to induce structural or functional abnormalities in embryonic development during prenatal exposure.

62

Publications

3.6K

Citations

220

Authors

98

Institutions

Publications per year

2017–2026

20

Authors

220

  1. PA
    Peter A. Fried

    Carleton University, Canada

    6 publications · 496 citations

    6

    h-index

  2. JF
    Javier Fernández‐Ruíz

    Universidad Complutense de Madrid, Spain

    2 publications · 67 citations

    2

    h-index

  3. TD
    Torri D. Metz

    University of Utah, United States

    2 publications · 44 citations

    2

    h-index

  4. AS
    Albert Stuart Reece

    The University of Western Australia, Australia

    2 publications · 147 citations

    2

    h-index

  5. YL
    Yasmin L. Hurd

    Icahn School of Medicine at Mount Sinai, United States

    2 publications · 201 citations

    2

    h-index

1–5 of 220

Venues

  1. Toxicology and Applied Pharmacology

    TAAP · 4 publications · 227 citations

    4

    h-index

  2. Neurotoxicology and Teratology

    4 publications · 363 citations

    4

    h-index

  3. PubMed

    Repository · 4 publications · 123 citations

    4

    h-index

  4. Teratology

    3 publications · 82 citations

    3

    h-index

  5. The Lancet

    3 publications · 241 citations

    3

    h-index

1–5